CACYBP Human

Calcyclin Binding Protein Human Recombinant
Cat. No.
BT28907
Source
Escherichia Coli.
Synonyms
S100A6BP, S100A6 Binding Protein, GIG5, PNAS-107, RP1-102G20.6, SIP, CACYBP, hCacyBP, Siah-interacting protein, MGC87971.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 85% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

CACYBP Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 205 amino acids (1-185a.a.) and having a molecular mass of 23.4 kDa. CACYBP protein is fused to a 20 amino acid His tag at N-terminus and is purified by standard chromatography.

Product Specs

Introduction
CACYBP (calcyclin binding protein) is involved in calcium-dependent ubiquitination, leading to the proteasomal degradation of specific target proteins. It functions as a link in ubiquitin E3 complexes and plays a role in the ubiquitin-mediated degradation of beta-catenin.
Description
Recombinant CACYBP Human, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 205 amino acids (1-185a.a.) with a molecular weight of 23.4 kDa. The protein includes a 20 amino acid His tag at the N-terminus and undergoes purification through standard chromatography techniques.
Physical Appearance
Clear, colorless solution, sterile filtered.
Formulation
CACYBP Human is supplied in a solution containing 20mM Tris HCl at pH 8, 1mM DTT, 0.1M NaCl, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is determined to be greater than 85% via SDS-PAGE analysis.
Synonyms
S100A6BP, S100A6 Binding Protein, GIG5, PNAS-107, RP1-102G20.6, SIP, CACYBP, hCacyBP, Siah-interacting protein, MGC87971.
Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MQQKSQKKAE LLDNEKPAAV VAPITTGYTV KISNYGWDQS DKFVKIYITL TGVHQVPTEN VQVHFTERSF DLLVKNLNGK SYSMIVNNLL KPISVEGSSK KVKTDTVLIL CRKKVENTRW DYLTQVEKEC KEKEKPSYDT ETDPSEGLMN VLKKIYEDGD DDMKRTINKA WVESREKQAK GDTEF.

Product Science Overview

Introduction

Calcyclin Binding Protein (CACYBP), also known as S100A6 Binding Protein, is a protein encoded by the CACYBP gene in humans. This protein is part of the S100 protein family, which is known for its role in calcium-binding. CACYBP is involved in various cellular processes, including calcium-dependent ubiquitination and proteosomal degradation of target proteins .

Discovery and Structure

CACYBP was first identified and purified over 30 years ago. It was initially studied for its calcium-binding properties and the resultant conformational changes upon binding with calcium ions. The protein’s structure has been extensively analyzed using biophysical methods, revealing its versatility in forming complexes with various ligands .

Expression and Localization

CACYBP is highly expressed in brain neurons and other tissues. It is localized in the cytoplasm, nucleus, and extracellular exosomes. The protein plays a crucial role in calcium-dependent cellular processes, including cell differentiation, proliferation, and response to stress .

Function and Mechanism

CACYBP serves as an adaptor protein in ubiquitin E3 complexes, participating in the ubiquitin-mediated degradation of β-catenin. This process is essential for regulating protein levels within the cell and maintaining cellular homeostasis. CACYBP also interacts with other proteins, such as SKP1A and SIAH1, forming complexes that are involved in stress responses and other cellular functions .

Pathological Implications

Altered expression of CACYBP has been observed in various pathological states, including cancers. The protein’s expression levels correlate with the stage and progression of certain diseases, suggesting its potential role as a biomarker. Research continues to explore the mechanisms by which CACYBP contributes to disease development and progression .

Human Recombinant CACYBP

Human recombinant CACYBP is produced using recombinant DNA technology, typically expressed in Escherichia coli (E. coli) systems. This recombinant form is used in research to study the protein’s function, interactions, and potential therapeutic applications. The availability of human recombinant CACYBP allows for detailed biochemical and structural analyses, facilitating a deeper understanding of its role in health and disease .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.